Distribution of GM and KM phenotypes in relation to IgG and IgM antibody levels to MUC1 in patients with gastric cancer
| Phenotypes . | No. subjects . | Antibody levels (median, interquartile range) . | . | |
|---|---|---|---|---|
| . | . | MUC1 IgG (RU) . | MUC1 IgM (RU) . | |
| GM 3 23 5,13 | 68 | 65.5* (41.5–121.5) | 32.5 (20.2–49.0) | |
| GM 1,3,17 23 5,13,21 | 32 | 84.5 (60.0–134.5) | 35.5 (23.0–43.0) | |
| GM 3 5,13 | 16 | 143.0 (51.0–283.0) | 31.0 (19.5–41.5) | |
| GM 1,3,17 5,13,21 | 14 | 71.5 (45.0–171.0) | 45.5 (16.0–65.0) | |
| GM 1,2,3,17 23 5,13,21 | 10 | 114.5 (101.0–149.0) | 24.0 (20.0–41.0) | |
| GM 1,2,3,17 5,13,21 | 10 | 158.0 (49.0–366.0) | 37.5 (28.0–47.0) | |
| Other GM | 19 | 69.0 (49.0–172.0) | 27.0 (15.0–42.0) | |
| KM 1 | 0 | NA | NA | |
| KM 1,3 | 20 | 88.0 (40.0–166.5) | 35.0 (18.5–52.5) | |
| KM 3 | 149 | 82.0 (48.0–145.0) | 33.0 (20.0–46.0) | |
| Phenotypes . | No. subjects . | Antibody levels (median, interquartile range) . | . | |
|---|---|---|---|---|
| . | . | MUC1 IgG (RU) . | MUC1 IgM (RU) . | |
| GM 3 23 5,13 | 68 | 65.5* (41.5–121.5) | 32.5 (20.2–49.0) | |
| GM 1,3,17 23 5,13,21 | 32 | 84.5 (60.0–134.5) | 35.5 (23.0–43.0) | |
| GM 3 5,13 | 16 | 143.0 (51.0–283.0) | 31.0 (19.5–41.5) | |
| GM 1,3,17 5,13,21 | 14 | 71.5 (45.0–171.0) | 45.5 (16.0–65.0) | |
| GM 1,2,3,17 23 5,13,21 | 10 | 114.5 (101.0–149.0) | 24.0 (20.0–41.0) | |
| GM 1,2,3,17 5,13,21 | 10 | 158.0 (49.0–366.0) | 37.5 (28.0–47.0) | |
| Other GM | 19 | 69.0 (49.0–172.0) | 27.0 (15.0–42.0) | |
| KM 1 | 0 | NA | NA | |
| KM 1,3 | 20 | 88.0 (40.0–166.5) | 35.0 (18.5–52.5) | |
| KM 3 | 149 | 82.0 (48.0–145.0) | 33.0 (20.0–46.0) | |
Abbreviation: NA, not applicable.
Significantly lower (P = 0.0058, obtained by analysis of covariance log10 transformed data) compared with the rest of the GM phenotypes.